. Proliferasi sel pada kultur jaringan hipokampus tikus pascahipoksia dengan pemberian ekstrak akar kucing pada dosis 10, 15, dan 20 mg/mL lebih tinggi secara bermakna dibandingkan dengan kontrol (0,132; 0,117; 0,114 vs. 0,096). 
Currently, the primary therapy for ischemic stroke is administration of thrombolytics, 1 because this is the only therapeutic approach that showed improvement of neurological function. 2 Unfortunately, the 3-hour therapeutic window for this therapy is very brief, 1 and it will increase the risk of hemorrhagic transformation. 3 This is why neurorestorative therapy with longer therapeutic window and actively improving neurological function to restore and optimize the brain function is necessary. 2, 3 Neurorestorative therapy will enhance the development of new nerve cells (neurogenesis) in the post stroke ischemic brain tissue. 3 In most adult mammalian brain, there are stem cells in the subgranular zone (SGZ) dentate gyrus (DG) of the hippocampus and subventricular zone (SVZ) of the lateral ventricle. 2, 4, 5 These stem cells can be stimulated by a variety of physiological and pathological factors such as hypoxia. 4, 5 Many studies have proven the ability of adult brain neurogenesis in the post-hypoxic cerebral tissue. 4, 5 In humans, neurogenesis induced by stroke has been reported by Jin et al. 6 Although the neurogenesis was increased naturally in the post-hypoxic cerebral tissue, the increased was not proportional to the damage that had been occurred. 7 One of the causes of cell death in stroke is the process of infl ammation, 8 with activation of the enzyme phospholipase A2 (PLA2), which will produce arachi-donic acid (AA). 9 ,10 AA will be metabolized through the cyclooxygenase (COX) pathway which will convert AA into prostaglandin H2 (PGH2). PGH2 is the precursor of further prostaglandins, which together with various other eicosanoids may increase the permeability of the blood brain barrier and ultimately cause brain edema. 10 Infl ammation has been proven to inhibit the basal and post-hypoxic neurogenesis. 11 One safe neurorestorative therapy approach is the mobilization of endogenous adult stem cell population in the central nervous system. These endogenous adult system cells can integrate and participate in the functional neural circuits. 12 One of the methods for stem cell mobilization is the decreasing of infl ammatory response. 13 Acalypha indica Linn (akar kucing) is a plant that can be found in every region in Indonesia. Empirically, people have used the roots of the plant to cure nerve paralysis caused by stroke.
14 Some of the active chemical compounds contained in the plant have been identifi ed, such as kaempferol (fl avonoids), betasitosterol, hydrogen cyanide, gamma-sitosterol, and acalyphin. 15 Nirmal et al. have proven that acalyphin and stigmasterol function as anti-infl ammatory agents by forming PLA2 inhibitor complexes. PLA2 is an important infl ammation precursor. 16 As mentioned above, decreasing of the infl ammatory response can increase the mobilization of endogenous adult stem cells population in the central nervous system. 13 Although empirically this plant has been used to cure paralysis in post-stroke patients, there is no scientifi c evidence yet on the effects of Acalypha indica Linn root extract on post-stroke neurogenesis. There are many parameters to measure neurogenesis, two of them are the relative cell viability and proliferation. 17 This research is aimed to observe the effect of Acalypha indica Linn root extract on relative cell viability and proliferation as parameters of neurogenesis in the posthypoxic hippocampal tissue in vitro.
METHODS

Study design and sample
An in vitro experimental study was conducted on primary neuronal cell cultures, which were taken from the hippocampus of adult Sprague Dawley rats aged 9-10 weeks weighing 200-250 grams. The experiment was conducted at the Oral Biology Laboratory, Faculty of Dentistry University of Indonesia from January to March 2010. The animals were sacrifi ced by cervical dislocation. The total number of samples was 24, divided equally into 4 groups (1 control group and 3 treatment groups) based on Federer formula. Ethical clearance was obtained from the committee of the medical research ethics of the Faculty of Medicine, University of Indonesia, and the management of animals used was in accordance to the Helsinki convention.
Culture of nerve cells
Nerve cells were cultured in petri dishes that have been coated with poly-L-lysine (Nacalai Tesque, Jakarta, Indonesia) for 1 hour. The nerve cells were then seeded into 1x10 6 cells/dish. Cultures were incubated (Inco 2 Memmert) with 5% CO2/95% air at 37° C. Dulbecco's Modifi ed Eagle Medium (DMEM) (GIBCO, Invitrogen, Jakarta, Indonesia) was used for culture medium and was replaced every 72 hours during the incubation period.
Cell harvest and plating
Nerve cell cultures were harvested on day 10 and identifi ed morphologically. The number of cells was counted using trypan blue and a hemocytometer. The nerve cells were then seeded into 24 well-plates at 5x10 5 cells/well and into 96 well-plates at 1x10 5 cells/ well, respectively. The multiwell culture plates had previously been coated with poly-L-lysine for 1 hour.
Exposure to hypoxia
Directly after plating, nerve cells were then exposed to hypoxia by administering 5% O2/5% CO2/N2 balance gas for 24 hours.
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Treatment with Acalypha indica Linn extract
Each treatment groups of nerve cell cultures were given Acalypha indica Linn root extract with doses of 10, 15, and 20 mg/mL. The control group was given no treatment. Acalypha indica Linn root extract was obtained from Department of Pharmacy, Faculty of Medicine University of Indonesia. The plates were reincubated with 5% CO2/95% air at 37°C for 90 hours.
Measurement of relative cell viability and proliferation
Relative cell viability and cell proliferation are two parameters of neurogenesis. 17 Relative cell viability was measured using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) examination from SIGMA. MTT assay was performed in triplicate. The result of MTT test indicates the number of post-hypoxic viable nerve cells, but the viable cells can be derived from new nerve cells resulting from neurogenesis or old nerve cells that survive post-hypoxia and did not undergo apoptosis. Therefore BrdU examination to assess the level of cell proliferation was performed. Cell proliferation was measured using 5-bromo2'-deoxy-uridine (BrdU) (Roche, Jakarta, Indonesia). BrdU examination was performed in duplicate. Cells from the 24 well-plates were used for MTT examination; cells from the 96 wellplates were used for BrdU examination.
Data analysis
Normality of data was tested by using Shapiro-Wilk test. Relative cell viability and cell proliferation data was compared between control and each treatment group by using one way ANOVA parametric test, and further analyzed with post-hoc analysis. Data processing was performed using Statistical Package for the Social Sciences (SPSS) version 16.0 software.
RESULTS
Relative Cell Viability
Mean relative cell viability in the control group was set to 100%, with values between 85.01 and 115.08 (SD +/-14.33, n = 6). In groups treated with Acalypha indica Linn extract at doses of 10, 15, and 20 mg/mL of extract, respectively, mean cell viability was 176.95% with values between 168.0 and 185.29 (SD +/-7.95, n = 6), 220.62% with values between 168.7 and 272.54 (SD +/-49.47, n = 6), 386.02% with values between 339.65 and 432.39 (SD +/-44.16, n = 6), consecutively (p = 0.000 in all treatment groups vs control; Fig. 1 ).
The relative cell viability in group treated with extract at dose of 15 mg/mL was signifi cantly higher than the relative cell viability in group treated with extract at dose of 10 mg/mL (p = 0.021), and the relative cell viability in group treated with extract at dose of 20 mg/mL was signifi cantly higher than the relative cell viability in group treated with dose of 15 mg/mL (p = 0.000; Fig. 1 ). 
Cell proliferation
DISCUSSION
MTT test results indicate that the relative cell viability of all treatment groups were signifi cantly higher than control, and showed dose-dependent relationship, even up to almost 4-fold at dose 20 mg/mL. The result of this examination showed that Acalypha indica Linn root extract has an effect on increasing the number of viable post-hypoxic nerve cells. The result was consistent with research by Purwaningsih et al. 14 in which the optimal neurotherapy dose was seen at dose 20 mg/mL. The dose-dependent increase in relative cell viability raises the possibility that a higher dose than 20 mg/mL would further enhance the cell viability, thus further research to assess the effect of Acalypha indica Linn root extract on relative cell viability of hippocampal tissue posthypoxia with higher doses needs to be performed to obtain the optimal dose for the increase of post-hypoxic relative cell viability.
The result of BrdU examination showed that the cell proliferation level in all treatment groups were signifi cantly higher than the control group. This means that the Acalypha indica Linn root extract has an effect on increasing the post-hypoxic cell proliferation level. The optimal cell proliferation level was found at the dose 10 mg/mL, and then decreased at dose 15 mg/mL and 20 mg/mL. There are two possible causes for this phenomenon. The fi rst is that the most optimal level of cell proliferation is indeed at the dose 10 mg/mL, thus the higher relative cell viability at the higher doses might be the result of old nerve cells that survive post-hypoxia and did not undergo apoptosis. This can occur due to the decrease in the infl ammatory response caused by a decrease in PLA2 enzyme activation by acalyphin and stigmasterol that will further decrease the occurrence of respiratory burst and ROS production by which more cells may survive post-hypoxia. 8 Stigmasterol also has antioxidant activity that can inhibit the production of ROS and ultimately improve the post-hypoxic survival of nerve cells. 19 Acalypha indica Linn also contains fl avonoids which possesses antioxidant activity and acts as free radicals scavenger. 20 The second possibility is that at the time of examination, not all new nerve cells resulting from neurogenesis can be detected by BrdU examination. This is because incorporation of BrdU can only occur when the cells are in S phase of the cell cycle, 21 thus new cells that have undergone proliferation before or which are going to undergo proliferation but were not in S phase cannot be detected by this examination. Therefore, further research with time serial BrdU examination (e.g. every 24 hours posthypoxia) needs to be performed to obtain a more accurate cell proliferation level. Examination with other cell proliferation markers can also be performed as comparison to the BrdU results, such as Ki-67 examination. 21 Increased relative cell viability and proliferation that occurs in the groups treated with Acalypha indica Linn root extract is most likely caused by inhibition of PLA2 enzyme activation that will reduce the infl ammatory response. This will then increase the mobilization of adult stem cells that already exist physiologically in the central nervous system and this in turn will increase relative cell viability and proliferation. 13 This mechanism was not studied in this research, thus further research to assess whether the effect Acalypha indica Linn root extract toward increased relative cell viability and proliferation post-hypoxia is caused by inhibition PLA2 activation by comparing the levels of PLA2 between treatment groups using a marker of PLA2 is needed.
Besides reduction in the infl ammatory response, Acalypha indica Linn root extract may also act by increasing neurotrophic factors such as BDNF, VEGF, and bFGF. Neurotrophic factors are necessary for the survival mechanism of neuroblast. 2 The increased relative cell viability and proliferation caused by Acalypha indica Linn root extract through this mechanism has not been investigated, thus further research to assess whether the Acalypha indica Linn root extract can enhance cell viability and proliferation post-hypoxia through enhanced neurotrophic factors by examining the levels of growth factors (e.g. BDNF) between treatment groups is needed.
This research has a limitation, which was the identifi cation of the neural cells in this study was performed morphologically. This method cannot identify the neural cells with full certainty because the identifi ed cells may be other cells also residing in the hippocampus, such as glial cells and fi broblasts. Thus, further research to positively identify the neural cells by using a specifi c marker or antibody such as neuron-specifi c enolase type 2 is needed.
From this research we can conclude that Acalypha indica Linn root extract at doses of 10, 15, and 20 mg/ mL can increase relative cell viability and proliferation post-hypoxia in vitro.
